Response of malignant B lymphocytes to ionizing radiation: Gene expression and genotype

Abstract

The human malignant B-lymphocyte cell lines Reh and U698 show arrest in G 2 phase after ionizing radiation (IR), but only Reh cells arrest in G 1 phase and die by apoptosis. We have used cDNA microarrays to measure changes in gene expression at 2, 4 and 6 hr after irradiation of Reh and U698 cells with 0.5 and 4 Gy in order to begin exploring the molecular mechanisms underlying the phenotypic changes. We also investigated whether gene expression changes could be caused by possible aberrations of genes, as measured by comparative genomic hybridization. Reh cells showed upregulation of CDKN1A that likely mediated the G 1 arrest. In contrast, U698 cells have impaired function of TP53 protein and no activation of CDKN1A, suppressing the arrest in G 1 . The G 2 arrest in both cell lines was likely due to repression of PLK1 and/or CCNF. IR-induced apoptosis in Reh cells was probably mediated by TP53 and CDKN1A, whereas a high expression level of MCL1, caused by gene amplification, and activation of the NFKB pathway may have suppressed the apoptotic response in U698 cells. Genes suggested to be involved in apoptosis were activated long before this phenotype was detectable and showed the same temporal expression profiles as genes involved in cell cycle arrest. Our results suggest that differences in functionality and/or copy number of several genes involved in IR-regulated pathways contributed to the phenotypic differences between Reh and U698 cells after IR, and that multiple molecular factors control the radiation response of malignant B lymphocytes. ' 2005 Wiley-Liss, Inc.

MicroRNA‐206 induces G1 arrest in melanoma by inhibition of CDK4 and Cyclin D

“…Second, we focused on miRs that had been previously shown to be differentially expressed in other cancers and that had oncogenes or tumor suppressors as predicted targets. One example is miR‐Let‐7c, which had been previously published as a tumor suppressor miR and has predicted targets shown to be associated with cancer, such as CCNF (De Angelis et al., ; Lyng et al., ; Roy et al., ), E2F2 (Dong et al., ; Pusapati et al., ; Rempel et al., ; Shen et al., ), E2F6 (Lu et al., ; Sanchez‐Beato et al., ), and RAS (He et al., ; Khodayari et al., ; Oh et al., ). Finally, a number of miRs were chosen solely for their bio‐informatically predicted ability to regulate the expression of known oncogenic and tumor suppressor genes.…”

Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progression

“…Moreover, down-modulation of PLK1 expression was found to inhibit growth of bladder cancer in mice [29]. Expression of PLK1 and CCNF (cyclin F), which contributes to the G 2 to M phase transition, have been related to response to radio and chemotherapy [30, 31]. From the “invasion” gene set, secreted protein acidic and rich in cysteine ( SPARC ) (also known as osteonectin) is overexpressed in CRCs and induces proinvasive activity [32].…”

A cyclin without cyclin-dependent kinases: cyclin F controls genome stability through ubiquitin-mediated proteolysis

“…Because dNTP production is critical for cell survival, additional mechanisms operate following genotoxic stress to regulate the cyclin F-RRM2 axis. For example, cyclin F mRNA levels decrease 6 hours after treatment of B lymphocytes with ionizing radiation [25]. Additionally, four RRM2 transcript variants have been found in zebrafish, and one of the four variants that is most highly expressed following the treatment of embryos with genotoxic stress lacks the first 52 amino acids, where the binding sites for cyclin F and Cdh1 reside.…”